SCHEMBL7654656

SCHEMBL7654656

CS(=O)(=O)OC(=O)COc1ccccc1-c1ccccc1C(=O)Nc1ccc(C(=N)N)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KLK1 P06870 5/20 0.55
KLK5 Q9Y337 5/20 0.55
PLAU P00749 5/20 0.50
PLAT P00750 5/20 0.50
F10 P00742 8/20 0.48
F2 P00734 5/20 0.48
PRSS1 P07477 3/20 0.48
PRSS2 P07478 2/20 0.48
PRSS3 P35030 2/20 0.48
F7 P08709 1/20 0.48
F3 P13726 1/20 0.48
PLG P00747 2/20 0.48
ALDH1A1 P00352 2/20 0.44
MCL1 Q07820 1/20 0.44
RECQL P46063 1/20 0.43
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
MAPT P10636 2/20 0.43
NPSR1 Q6W5P4 1/20 0.43
CYP1A2 P05177 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7654641 0.88 KLK1 (0.54) KLK1KLK5PLAUPLATF10
SCHEMBL7662316 0.85 KLK1 (0.53) KLK1KLK5PLAUPLATF10
SCHEMBL7659146 0.85 PLAU (0.53) KLK1KLK5PLAUPLATF10
SCHEMBL7659161 0.84 PLAU (0.60) KLK1KLK5PLAUPLATF10
SCHEMBL7663117 0.83 F10 (0.56) KLK1KLK5PLAUPLATF10
SCHEMBL7652005 0.82 PLAU (0.50) KLK1KLK5PLAUPLATF10
SCHEMBL7659243 0.80 KLK1 (0.61) KLK1KLK5PLAUPLATF10
SCHEMBL7665910 0.80 KLK1 (0.54) KLK1KLK5PLAUPLATF10
SCHEMBL7663676 0.79 F10 (0.52) KLK1KLK5PLAUPLATF10
SCHEMBL7658935 0.79 F10 (0.51) KLK1KLK5PLAUPLATF10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6358960-B1 FOR THERAPY OF INTRAVASCULAR COAGULATION, CORONARY THROMBOSIS, CEREBRAL INFARCTION, CEREBRAL EMBOLISM, TRANSIENT ISCHEMIC ATTACK, CEREBROVASCULAR DISORDERS, PULMONARY VASCULAR DISEASES, DEEP VENOUS THROMBOSIS, ETC. ONO PHARMACEUTICAL CO., LTD. (JP) 2002-03-19 US disclosed
EP-1078917-A1 AMIDINO DERIVATIVES AND DRUGS CONTAINING THE SAME AS THE ACTIVE INGREDIENT ONO PHARMACEUTICAL CO., LTD. (JP) 2001-02-28 EP disclosed